mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.2 |
3e-05 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-05 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |